Moreover, the importance of targeting both the tumour directly, in addition to surrounding TF-rich stromal cells within the tumour microenvironment was shown via the use of liposomes conjugated to both anti-human and anti-murine TF antibodies, where pancreatic tumour cells (BxPC3) of human origin were xenografted into mice, while the stromal cells of the tumour microenvironment were of murine origin [47]. The gene discussed is TF; the disease is neoplasm.